We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTES icon
12951
PUT
Gates Industrial Corp
GTES
$7.03B
$22.8K ﹤0.01%
+2,000
New +$22K
ACH
12952
Accendra Health
ACH
$73.1M
$22.8K ﹤0.01%
1,166
-329,667
-100% -$6.43M
RUBY
12953
DELISTED
Rubius Therapeutics, Inc
RUBY
$22.8K ﹤0.01%
132,322
-9,458
-7% -$2.58K
MSDAW
12954
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$22.7K ﹤0.01%
302,863
+2,763
+0.9% +$176
REED
12955
DELISTED
Reeds, Inc. Common Stock
REED
$22.7K ﹤0.01%
+6,503
New +$36.6K
CARM
12956
PUT
DELISTED
Carisma Therapeutics
CARM
$22.6K ﹤0.01%
1,855
-680
-27% -$7.14K
HOWL icon
12957
Werewolf Therapeutics
HOWL
$19.7M
$22.6K ﹤0.01%
+11,030
New +$28.9K
HRT
12958
PUT
DELISTED
HireRight Holdings Corporation
HRT
$22.5K ﹤0.01%
+1,900
New +$23.6K
CWAN
12959
PUT
DELISTED
Clearwater Analytics
CWAN
$22.5K ﹤0.01%
1,200
-10,300
-90% -$178K
ACHL
12960
DELISTED
Achilles Therapeutics
ACHL
$22.5K ﹤0.01%
+24,994
New +$42.1K
CULP icon
12961
PUT
Culp Inc
CULP
$42.1M
$22.5K ﹤0.01%
4,900
-27,800
-85% -$131K
KUST
12962
PUT
Kustom Entertainment Inc
KUST
$771K
0
MAMA icon
12963
Mama's Creations
MAMA
$802M
$22.5K ﹤0.01%
12,516
-9,696
-44% -$11.6K
HIW icon
12964
PUT
Highwoods Properties
HIW
$3.48B
$22.4K ﹤0.01%
+800
New +$22.2K
DUSL icon
12965
CALL
Direxion Daily Industrials Bull 3X ETF
DUSL
$62.7M
$22.4K ﹤0.01%
+700
New +$20.9K
GIC icon
12966
Global Industrial
GIC
$1.48B
$22.3K ﹤0.01%
948
-7,480
-89% -$194K
ATRA icon
12967
PUT
Atara Biotherapeutics
ATRA
$81.2M
$22.3K ﹤0.01%
+272
New +$28.3K
VAPO
12968
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$22.3K ﹤0.01%
+1,032
New +$11.7K
VRCA icon
12969
PUT
Verrica Pharmaceuticals
VRCA
$85.4M
$22.3K ﹤0.01%
810
-2,290
-74% -$61.1K
NMFC icon
12970
PUT
New Mountain Finance
NMFC
$730M
$22.3K ﹤0.01%
+1,800
New +$22.2K
BACK
12971
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$22.3K ﹤0.01%
+3,711
New +$35.9K
ENTX icon
12972
Entera Bio
ENTX
$500M
$22.2K ﹤0.01%
+30,465
New +$22.1K
TIRX
12973
DELISTED
Tian Ruixiang Holdings
TIRX
$22.2K ﹤0.01%
478
+88
+23% +$5.73K
BMO icon
12974
Bank of Montreal
BMO
$130B
$22.2K ﹤0.01%
245
-4,102
-94% -$380K
ATRC icon
12975
CALL
AtriCure
ATRC
$2.25B
$22.2K ﹤0.01%
500
-7,000
-93% -$292K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.